Notably, although the genomic function of AR is considered to be the main role of this nuclear receptor, lots of binding partners of AR have been described in the cytoplasm highlighting a fine tuning of AR non-genomic pathways whose involvement in prostate cancer disease and progression is currently subject to debate. Here, AR is linked to prostate cancer.